Purulent pericarditis due to methicillin-resistant Staphylococcus aureus. A case report.
Purulent pericarditis is an infrequent complication of infections originating in another body location. Symptoms and signs are often absent; a high index of awareness is required for its diagnosis. A patient recovering from extensive necrotic-hemorrhagic pancreatitis presented with tamponade due to methicillin-resistant Staphylococcus aureus (MRSA) purulent pericarditis, further complicated by MRSA endocarditis. Treatment included pericardectomy, IV vancomycin and teicoplanin.
Demey
H E
HE
Department of Intensive Care, University Hospital Antwerp (U.I.A.), Edegem, Belgium.
Eycken
M
M
Vandermast
M
M
Bossaert
L L
LL
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002764:Cholecystitis / Q000150:complications; D004697:Endocarditis, Bacterial / Q000150:complications / Q000382:microbiology; D006020:Glycopeptides / Q000627:therapeutic use; D006801:Humans; D008297:Male; D016106:Methicillin Resistance; D008875:Middle Aged; D010195:Pancreatitis / Q000150:complications* / Q000188:drug therapy / Q000209:etiology; D010492:Pericardiectomy; D010493:Pericarditis / Q000150:complications / Q000382:microbiology* / Q000628:therapy; D013203:Staphylococcal Infections / Q000150:complications / Q000382:microbiology* / Q000628:therapy; D013211:Staphylococcus aureus / Q000302:isolation & purification; D017334:Teicoplanin; D014640:Vancomycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D017334:Teicoplanin; D014640:Vancomycin